Cargando…
New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design, Synthesis, Antiproliferative, and Computational Studies
Herein, 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline was used as a bio-isosteric scaffold to the phthalazinone motif of the standard drug Olaparib to design and synthesize new derivatives of potential PARP-1 inhibitory activity using the 6-sulfonohydrazide analog 3 as the key intermediate. Although the n...
Autores principales: | Syam, Yasmin M., Anwar, Manal M., Abd El-Karim, Somaia S., Elokely, Khaled M., Abdelwahed, Sameh H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370283/ https://www.ncbi.nlm.nih.gov/pubmed/35956876 http://dx.doi.org/10.3390/molecules27154924 |
Ejemplares similares
-
New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studies
por: Syam, Yasmin M., et al.
Publicado: (2021) -
New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies
por: Alanazi, Mohammed M., et al.
Publicado: (2021) -
A Comparative Study of the Anticancer Activity and PARP-1 Inhibiting Effect of Benzofuran–Pyrazole Scaffold and Its Nano-Sized Particles in Human Breast Cancer Cells
por: Anwar, Manal M., et al.
Publicado: (2019) -
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
por: Montero, Vincent, et al.
Publicado: (2022) -
Mechanisms underlying the antiproliferative effects of a series of quinoxaline-derived chalcones
por: Mielcke, Tânia R., et al.
Publicado: (2017)